Perspective has delivered initial clinical data for two new potential medicines based on its next generation targeted radiopharmaceutical technology platform, and is poised to do more in the next 18 ...
Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications ...